Largest Swedish (OMX) Pharmaceuticals & Biotech Stocks by Market Cap

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Apr 06, 2026

Discover large cap Swedish Pharmaceuticals & Biotech companies that are on the OMX. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

94 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
SOBI	SEK 400.80	2.2%	50.8%	SEK 138.5b	SEK 428.50	289.8	28.5%	n/a
BIOA B	SEK 327.40	2.3%	92.1%	SEK 29.0b	SEK 303.80	28.4	-20.1%	0.6%
CAMX	SEK 472.00	1.1%	-12.1%	SEK 28.9b	SEK 768.00	38.3	32.9%	n/a
ALIF B	SEK 142.00	1.8%	-2.3%	SEK 17.3b	SEK 187.50	30.9	13.6%	1.1%
BONEX	SEK 214.20	9.9%	-31.2%	SEK 14.3b	SEK 366.60	100.6	34.6%	n/a
VITR	SEK 94.40	0.2%	-38.5%	SEK 12.6b	SEK 163.40	3.7	106.4%	1.2%
BIOG B	SEK 116.90	-2.1%	15.6%	SEK 11.8b	SEK 140.00	35.5	16.4%	3.4%
MCAP	SEK 475.00	1.6%	32.1%	SEK 7.1b	SEK 563.00	32.5	15.1%	n/a
SECARE	SEK 25.20	4.3%	-29.6%	SEK 4.0b	SEK 47.00	72.6	47.0%	1.1%
HNSA	SEK 32.68	2.5%	45.1%	SEK 3.3b	SEK 80.83	15.0	47.6%	n/a
VICO	SEK 10.18	1.8%	46.5%	SEK 2.9b	SEK 32.40	750.8	-11.4%	n/a
FLERIE	SEK 29.50	-19.0%	-28.0%	SEK 2.4b	SEK 45.00	939.8	n/a	n/a
EGTX	SEK 5.90	7.3%	44.4%	SEK 2.3b	SEK 9.40	37.4	91.6%	n/a
SANION	SEK 16.36	4.1%	159.7%	SEK 2.3b	SEK 19.00	7.9	-6.7%	n/a
CRNO B	SEK 6.49	3.9%	7.8%	SEK 2.0b	SEK 20.00	45.7	-26.7%	n/a
BINV	SEK 21.90	-1.6%	-19.8%	SEK 1.5b	SEK 96.67	6.4	40.5%	n/a
DVYSR	SEK 77.30	2.1%	-15.0%	SEK 1.3b	SEK 155.83	5.1	68.3%	n/a
GENO	SEK 19.44	7.6%	5.2%	SEK 1.3b	SEK 33.33	54.7	33.7%	n/a
MVIR	SEK 2.35	-5.4%	89.4%	SEK 1.3b	SEK 5.43	148.6	-10.0%	n/a
BICO	SEK 17.16	2.8%	-49.9%	SEK 1.2b	SEK 30.67	0.7	98.6%	n/a
XSPRAY	SEK 28.00	-5.7%	0.7%	SEK 1.2b	SEK 60.00	474.0	56.9%	n/a
SYNACT	SEK 18.22	-0.3%	0.1%	SEK 1.0b	SEK 34.65	6.0	64.9%	n/a
CANTA	SEK 4.03	-1.3%	216.8%	SEK 1.0b	SEK 11.25	6.8	-69.7%	n/a
CURAS	DKK 14.15	1.4%	102.1%	DKK 684.2m	n/a	38.1	n/a	n/a

Page 1 of 4